- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global Cancer Oncology Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cancer Oncology Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cancer Oncology Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cancer Oncology Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cancer Oncology Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cancer Oncology Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Oncology Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Oncology Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Devyser, Agendia, Illumina, Personal Genome Diagnostics and Veracyte, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cancer Oncology Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market segment by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Market segment by players, this report covers
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Oncology Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Oncology Testing, with revenue, gross margin and global market share of Cancer Oncology Testing from 2018 to 2023.
Chapter 3, the Cancer Oncology Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cancer Oncology Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Oncology Testing.
Chapter 13, to describe Cancer Oncology Testing research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cancer Oncology Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Oncology Testing by Type
1.3.1 Overview: Global Cancer Oncology Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cancer Oncology Testing Consumption Value Market Share by Type in 2022
1.3.3 Fluorescence In Situ Hybridization
1.3.4 Polymerase Chain Reaction
1.3.5 Microarray Technology
1.3.6 Serum Proteomics
1.3.7 Nucleic Acid Sequencing
1.4 Global Cancer Oncology Testing Market by Application
1.4.1 Overview: Global Cancer Oncology Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Speciality Clinics
1.4.4 Research Institutes
1.4.5 Diagnostics Laboratories
1.4.6 Biopharmaceutical Companies
1.5 Global Cancer Oncology Testing Market Size & Forecast
1.6 Global Cancer Oncology Testing Market Size and Forecast by Region
1.6.1 Global Cancer Oncology Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cancer Oncology Testing Market Size by Region, (2018-2029)
1.6.3 North America Cancer Oncology Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Cancer Oncology Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cancer Oncology Testing Market Size and Prospect (2018-2029)
1.6.6 South America Cancer Oncology Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cancer Oncology Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Devyser
2.1.1 Devyser Details
2.1.2 Devyser Major Business
2.1.3 Devyser Cancer Oncology Testing Product and Solutions
2.1.4 Devyser Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Devyser Recent Developments and Future Plans
2.2 Agendia
2.2.1 Agendia Details
2.2.2 Agendia Major Business
2.2.3 Agendia Cancer Oncology Testing Product and Solutions
2.2.4 Agendia Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Agendia Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Cancer Oncology Testing Product and Solutions
2.3.4 Illumina Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Personal Genome Diagnostics
2.4.1 Personal Genome Diagnostics Details
2.4.2 Personal Genome Diagnostics Major Business
2.4.3 Personal Genome Diagnostics Cancer Oncology Testing Product and Solutions
2.4.4 Personal Genome Diagnostics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Personal Genome Diagnostics Recent Developments and Future Plans
2.5 Veracyte
2.5.1 Veracyte Details
2.5.2 Veracyte Major Business
2.5.3 Veracyte Cancer Oncology Testing Product and Solutions
2.5.4 Veracyte Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Veracyte Recent Developments and Future Plans
2.6 Pacific Biosciences of California
2.6.1 Pacific Biosciences of California Details
2.6.2 Pacific Biosciences of California Major Business
2.6.3 Pacific Biosciences of California Cancer Oncology Testing Product and Solutions
2.6.4 Pacific Biosciences of California Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pacific Biosciences of California Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Cancer Oncology Testing Product and Solutions
2.7.4 Qiagen Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies Cancer Oncology Testing Product and Solutions
2.8.4 Agilent Technologies Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Agilent Technologies Recent Developments and Future Plans
2.9 Natera
2.9.1 Natera Details
2.9.2 Natera Major Business
2.9.3 Natera Cancer Oncology Testing Product and Solutions
2.9.4 Natera Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Natera Recent Developments and Future Plans
2.10 Bio Rad Laboratories
2.10.1 Bio Rad Laboratories Details
2.10.2 Bio Rad Laboratories Major Business
2.10.3 Bio Rad Laboratories Cancer Oncology Testing Product and Solutions
2.10.4 Bio Rad Laboratories Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bio Rad Laboratories Recent Developments and Future Plans
2.11 Myriad Genetics
2.11.1 Myriad Genetics Details
2.11.2 Myriad Genetics Major Business
2.11.3 Myriad Genetics Cancer Oncology Testing Product and Solutions
2.11.4 Myriad Genetics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Myriad Genetics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Oncology Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cancer Oncology Testing by Company Revenue
3.2.2 Top 3 Cancer Oncology Testing Players Market Share in 2022
3.2.3 Top 6 Cancer Oncology Testing Players Market Share in 2022
3.3 Cancer Oncology Testing Market: Overall Company Footprint Analysis
3.3.1 Cancer Oncology Testing Market: Region Footprint
3.3.2 Cancer Oncology Testing Market: Company Product Type Footprint
3.3.3 Cancer Oncology Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Cancer Oncology Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cancer Oncology Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Cancer Oncology Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Cancer Oncology Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Cancer Oncology Testing Consumption Value by Type (2018-2029)
6.2 North America Cancer Oncology Testing Consumption Value by Application (2018-2029)
6.3 North America Cancer Oncology Testing Market Size by Country
6.3.1 North America Cancer Oncology Testing Consumption Value by Country (2018-2029)
6.3.2 United States Cancer Oncology Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Cancer Oncology Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Cancer Oncology Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Cancer Oncology Testing Consumption Value by Type (2018-2029)
7.2 Europe Cancer Oncology Testing Consumption Value by Application (2018-2029)
7.3 Europe Cancer Oncology Testing Market Size by Country
7.3.1 Europe Cancer Oncology Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Cancer Oncology Testing Market Size and Forecast (2018-2029)
7.3.3 France Cancer Oncology Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cancer Oncology Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Cancer Oncology Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Cancer Oncology Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Cancer Oncology Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cancer Oncology Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cancer Oncology Testing Market Size by Region
8.3.1 Asia-Pacific Cancer Oncology Testing Consumption Value by Region (2018-2029)
8.3.2 China Cancer Oncology Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Cancer Oncology Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Cancer Oncology Testing Market Size and Forecast (2018-2029)
8.3.5 India Cancer Oncology Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cancer Oncology Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Cancer Oncology Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Cancer Oncology Testing Consumption Value by Type (2018-2029)
9.2 South America Cancer Oncology Testing Consumption Value by Application (2018-2029)
9.3 South America Cancer Oncology Testing Market Size by Country
9.3.1 South America Cancer Oncology Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Cancer Oncology Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Cancer Oncology Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Cancer Oncology Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cancer Oncology Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cancer Oncology Testing Market Size by Country
10.3.1 Middle East & Africa Cancer Oncology Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Cancer Oncology Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cancer Oncology Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Cancer Oncology Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Cancer Oncology Testing Market Drivers
11.2 Cancer Oncology Testing Market Restraints
11.3 Cancer Oncology Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Cancer Oncology Testing Industry Chain
12.2 Cancer Oncology Testing Upstream Analysis
12.3 Cancer Oncology Testing Midstream Analysis
12.4 Cancer Oncology Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Cancer Oncology Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cancer Oncology Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cancer Oncology Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cancer Oncology Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Devyser Company Information, Head Office, and Major Competitors
Table 6. Devyser Major Business
Table 7. Devyser Cancer Oncology Testing Product and Solutions
Table 8. Devyser Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Devyser Recent Developments and Future Plans
Table 10. Agendia Company Information, Head Office, and Major Competitors
Table 11. Agendia Major Business
Table 12. Agendia Cancer Oncology Testing Product and Solutions
Table 13. Agendia Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Agendia Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Cancer Oncology Testing Product and Solutions
Table 18. Illumina Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Personal Genome Diagnostics Company Information, Head Office, and Major Competitors
Table 21. Personal Genome Diagnostics Major Business
Table 22. Personal Genome Diagnostics Cancer Oncology Testing Product and Solutions
Table 23. Personal Genome Diagnostics Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Personal Genome Diagnostics Recent Developments and Future Plans
Table 25. Veracyte Company Information, Head Office, and Major Competitors
Table 26. Veracyte Major Business
Table 27. Veracyte Cancer Oncology Testing Product and Solutions
Table 28. Veracyte Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Veracyte Recent Developments and Future Plans
Table 30. Pacific Biosciences of California Company Information, Head Office, and Major Competitors
Table 31. Pacific Biosciences of California Major Business
Table 32. Pacific Biosciences of California Cancer Oncology Testing Product and Solutions
Table 33. Pacific Biosciences of California Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pacific Biosciences of California Recent Developments and Future Plans
Table 35. Qiagen Company Information, Head Office, and Major Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Cancer Oncology Testing Product and Solutions
Table 38. Qiagen Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Qiagen Recent Developments and Future Plans
Table 40. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 41. Agilent Technologies Major Business
Table 42. Agilent Technologies Cancer Oncology Testing Product and Solutions
Table 43. Agilent Technologies Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Agilent Technologies Recent Developments and Future Plans
Table 45. Natera Company Information, Head Office, and Major Competitors
Table 46. Natera Major Business
Table 47. Natera Cancer Oncology Testing Product and Solutions
Table 48. Natera Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Natera Recent Developments and Future Plans
Table 50. Bio Rad Laboratories Company Information, Head Office, and Major Competitors
Table 51. Bio Rad Laboratories Major Business
Table 52. Bio Rad Laboratories Cancer Oncology Testing Product and Solutions
Table 53. Bio Rad Laboratories Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Bio Rad Laboratories Recent Developments and Future Plans
Table 55. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 56. Myriad Genetics Major Business
Table 57. Myriad Genetics Cancer Oncology Testing Product and Solutions
Table 58. Myriad Genetics Cancer Oncology Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Myriad Genetics Recent Developments and Future Plans
Table 60. Global Cancer Oncology Testing Revenue (USD Million) by Players (2018-2023)
Table 61. Global Cancer Oncology Testing Revenue Share by Players (2018-2023)
Table 62. Breakdown of Cancer Oncology Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Cancer Oncology Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Cancer Oncology Testing Players
Table 65. Cancer Oncology Testing Market: Company Product Type Footprint
Table 66. Cancer Oncology Testing Market: Company Product Application Footprint
Table 67. Cancer Oncology Testing New Market Entrants and Barriers to Market Entry
Table 68. Cancer Oncology Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Cancer Oncology Testing Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Cancer Oncology Testing Consumption Value Share by Type (2018-2023)
Table 71. Global Cancer Oncology Testing Consumption Value Forecast by Type (2024-2029)
Table 72. Global Cancer Oncology Testing Consumption Value by Application (2018-2023)
Table 73. Global Cancer Oncology Testing Consumption Value Forecast by Application (2024-2029)
Table 74. North America Cancer Oncology Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Cancer Oncology Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Cancer Oncology Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Cancer Oncology Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Cancer Oncology Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Cancer Oncology Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Cancer Oncology Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Cancer Oncology Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Cancer Oncology Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Cancer Oncology Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Cancer Oncology Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Cancer Oncology Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Cancer Oncology Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Cancer Oncology Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Cancer Oncology Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Cancer Oncology Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Cancer Oncology Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Cancer Oncology Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Cancer Oncology Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Cancer Oncology Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Cancer Oncology Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Cancer Oncology Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Cancer Oncology Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Cancer Oncology Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Cancer Oncology Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Cancer Oncology Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Cancer Oncology Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Cancer Oncology Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Cancer Oncology Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Cancer Oncology Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Cancer Oncology Testing Raw Material
Table 105. Key Suppliers of Cancer Oncology Testing Raw Materials
List of Figures
Figure 1. Cancer Oncology Testing Picture
Figure 2. Global Cancer Oncology Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cancer Oncology Testing Consumption Value Market Share by Type in 2022
Figure 4. Fluorescence In Situ Hybridization
Figure 5. Polymerase Chain Reaction
Figure 6. Microarray Technology
Figure 7. Serum Proteomics
Figure 8. Nucleic Acid Sequencing
Figure 9. Global Cancer Oncology Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Cancer Oncology Testing Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Picture
Figure 12. Speciality Clinics Picture
Figure 13. Research Institutes Picture
Figure 14. Diagnostics Laboratories Picture
Figure 15. Biopharmaceutical Companies Picture
Figure 16. Global Cancer Oncology Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Cancer Oncology Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Cancer Oncology Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Cancer Oncology Testing Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Cancer Oncology Testing Consumption Value Market Share by Region in 2022
Figure 21. North America Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Cancer Oncology Testing Revenue Share by Players in 2022
Figure 27. Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Cancer Oncology Testing Market Share in 2022
Figure 29. Global Top 6 Players Cancer Oncology Testing Market Share in 2022
Figure 30. Global Cancer Oncology Testing Consumption Value Share by Type (2018-2023)
Figure 31. Global Cancer Oncology Testing Market Share Forecast by Type (2024-2029)
Figure 32. Global Cancer Oncology Testing Consumption Value Share by Application (2018-2023)
Figure 33. Global Cancer Oncology Testing Market Share Forecast by Application (2024-2029)
Figure 34. North America Cancer Oncology Testing Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Cancer Oncology Testing Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Cancer Oncology Testing Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Cancer Oncology Testing Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Cancer Oncology Testing Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Cancer Oncology Testing Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 44. France Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Cancer Oncology Testing Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Cancer Oncology Testing Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Cancer Oncology Testing Consumption Value Market Share by Region (2018-2029)
Figure 51. China Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 54. India Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Cancer Oncology Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Cancer Oncology Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Cancer Oncology Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Cancer Oncology Testing Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Cancer Oncology Testing Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Cancer Oncology Testing Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 68. Cancer Oncology Testing Market Drivers
Figure 69. Cancer Oncology Testing Market Restraints
Figure 70. Cancer Oncology Testing Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Cancer Oncology Testing in 2022
Figure 73. Manufacturing Process Analysis of Cancer Oncology Testing
Figure 74. Cancer Oncology Testing Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
